158 related articles for article (PubMed ID: 34212389)
1. ErbB4 mediates amyloid β-induced neurotoxicity through JNK/tau pathway activation: Implications for Alzheimer's disease.
Zhang H; Zhang L; Zhou D; Li H; Xu Y
J Comp Neurol; 2021 Oct; 529(15):3497-3512. PubMed ID: 34212389
[TBL] [Abstract][Full Text] [Related]
2. Ablating ErbB4 in PV neurons attenuates synaptic and cognitive deficits in an animal model of Alzheimer's disease.
Zhang H; Zhang L; Zhou D; He X; Wang D; Pan H; Zhang X; Mei Y; Qian Q; Zheng T; Jones FE; Sun B
Neurobiol Dis; 2017 Oct; 106():171-180. PubMed ID: 28684271
[TBL] [Abstract][Full Text] [Related]
3. The regulation of p53 up-regulated modulator of apoptosis by JNK/c-Jun pathway in β-amyloid-induced neuron death.
Akhter R; Sanphui P; Das H; Saha P; Biswas SC
J Neurochem; 2015 Sep; 134(6):1091-103. PubMed ID: 25891762
[TBL] [Abstract][Full Text] [Related]
4. Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.
Ma QL; Yang F; Rosario ER; Ubeda OJ; Beech W; Gant DJ; Chen PP; Hudspeth B; Chen C; Zhao Y; Vinters HV; Frautschy SA; Cole GM
J Neurosci; 2009 Jul; 29(28):9078-89. PubMed ID: 19605645
[TBL] [Abstract][Full Text] [Related]
5. Aβ monomer induces phosphorylation of Tau at Ser-214 through β2AR-PKA-JNK signaling pathway.
Wu H; Wei S; Huang Y; Chen L; Wang Y; Wu X; Zhang Z; Pei Y; Wang D
FASEB J; 2020 Apr; 34(4):5092-5105. PubMed ID: 32067279
[TBL] [Abstract][Full Text] [Related]
6. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
[TBL] [Abstract][Full Text] [Related]
7. β2 adrenergic receptor, protein kinase A (PKA) and c-Jun N-terminal kinase (JNK) signaling pathways mediate tau pathology in Alzheimer disease models.
Wang D; Fu Q; Zhou Y; Xu B; Shi Q; Igwe B; Matt L; Hell JW; Wisely EV; Oddo S; Xiang YK
J Biol Chem; 2013 Apr; 288(15):10298-307. PubMed ID: 23430246
[TBL] [Abstract][Full Text] [Related]
8. Amyloid-β toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer's disease.
Lloret A; Badia MC; Giraldo E; Ermak G; Alonso MD; Pallardó FV; Davies KJ; Viña J
J Alzheimers Dis; 2011; 27(4):701-9. PubMed ID: 21876249
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-β toxicity modulates tau phosphorylation through the PAX6 signalling pathway.
Zhang Y; Zhang Y; Aman Y; Ng CT; Chau WH; Zhang Z; Yue M; Bohm C; Jia Y; Li S; Yuan Q; Griffin J; Chiu K; Wong DSM; Wang B; Jin D; Rogaeva E; Fraser PE; Fang EF; St George-Hyslop P; Song YQ
Brain; 2021 Oct; 144(9):2759-2770. PubMed ID: 34428276
[TBL] [Abstract][Full Text] [Related]
10. Neuregulin1beta1 antagonizes apoptosis via ErbB4-dependent activation of PI3-kinase/Akt in APP/PS1 transgenic mice.
Cui W; Tao J; Wang Z; Ren M; Zhang Y; Sun Y; Peng Y; Li R
Neurochem Res; 2013 Nov; 38(11):2237-46. PubMed ID: 23982319
[TBL] [Abstract][Full Text] [Related]
11. Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway.
Killick R; Ribe EM; Al-Shawi R; Malik B; Hooper C; Fernandes C; Dobson R; Nolan PM; Lourdusamy A; Furney S; Lin K; Breen G; Wroe R; To AW; Leroy K; Causevic M; Usardi A; Robinson M; Noble W; Williamson R; Lunnon K; Kellie S; Reynolds CH; Bazenet C; Hodges A; Brion JP; Stephenson J; Simons JP; Lovestone S
Mol Psychiatry; 2014 Jan; 19(1):88-98. PubMed ID: 23164821
[TBL] [Abstract][Full Text] [Related]
12. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
eNeuro; 2017; 4(2):. PubMed ID: 28374012
[TBL] [Abstract][Full Text] [Related]
13. Differential accumulation of Tau phosphorylated at residues Thr231, Ser262 and Thr205 in hippocampal interneurons and its modulation by Tau mutations (VLW) and amyloid-β peptide.
Dávila-Bouziguet E; Targa-Fabra G; Ávila J; Soriano E; Pascual M
Neurobiol Dis; 2019 May; 125():232-244. PubMed ID: 30553886
[TBL] [Abstract][Full Text] [Related]
14. Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition.
Savage MJ; Lin YG; Ciallella JR; Flood DG; Scott RW
J Neurosci; 2002 May; 22(9):3376-85. PubMed ID: 11978814
[TBL] [Abstract][Full Text] [Related]
15. The novel calpain inhibitor A-705253 potently inhibits oligomeric beta-amyloid-induced dynamin 1 and tau cleavage in hippocampal neurons.
Sinjoanu RC; Kleinschmidt S; Bitner RS; Brioni JD; Moeller A; Ferreira A
Neurochem Int; 2008 Sep; 53(3-4):79-88. PubMed ID: 18590784
[TBL] [Abstract][Full Text] [Related]
16. STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's beta-amyloid deposits.
Cancino GI; Toledo EM; Leal NR; Hernandez DE; Yévenes LF; Inestrosa NC; Alvarez AR
Brain; 2008 Sep; 131(Pt 9):2425-42. PubMed ID: 18559370
[TBL] [Abstract][Full Text] [Related]
17. Blockade of Tau hyperphosphorylation and Aβ₁₋₄₂ generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and σ₁ receptor agonist, in a nontransgenic mouse model of Alzheimer's disease.
Lahmy V; Meunier J; Malmström S; Naert G; Givalois L; Kim SH; Villard V; Vamvakides A; Maurice T
Neuropsychopharmacology; 2013 Aug; 38(9):1706-23. PubMed ID: 23493042
[TBL] [Abstract][Full Text] [Related]
18. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.
Nussbaum JM; Schilling S; Cynis H; Silva A; Swanson E; Wangsanut T; Tayler K; Wiltgen B; Hatami A; Rönicke R; Reymann K; Hutter-Paier B; Alexandru A; Jagla W; Graubner S; Glabe CG; Demuth HU; Bloom GS
Nature; 2012 May; 485(7400):651-5. PubMed ID: 22660329
[TBL] [Abstract][Full Text] [Related]
19. Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway.
Vukic V; Callaghan D; Walker D; Lue LF; Liu QY; Couraud PO; Romero IA; Weksler B; Stanimirovic DB; Zhang W
Neurobiol Dis; 2009 Apr; 34(1):95-106. PubMed ID: 19162185
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory Neural Network's Impairments at Hippocampal CA1 LTP in an Aged Transgenic Mouse Model of Alzheimer's Disease.
Seo HJ; Park JE; Choi SM; Kim T; Cho SH; Lee KH; Song WK; Song J; Jeong HS; Kim DH; Kim BC
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
